loading
Schlusskurs vom Vortag:
$3.37
Offen:
$3.39
24-Stunden-Volumen:
7,797
Relative Volume:
0.10
Marktkapitalisierung:
$57.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.58%
1M Leistung:
-7.10%
6M Leistung:
-9.81%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$3.311
$3.41
1-Wochen-Bereich:
Value
$3.30
$3.53
52-Wochen-Spanne:
Value
$2.88
$6.00

Mural Oncology Plc Stock (MURA) Company Profile

Name
Firmenname
Mural Oncology Plc
Name
Telefon
353 1 905 8020
Name
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Name
Mitarbeiter
109
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
MURA's Discussions on Twitter

Vergleichen Sie MURA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
MURA 3.41 57.42M 0 0 0 0.00
VRTX 448.67 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.97 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 588.56 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.22 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.27 24.49B 3.30B -501.07M 1.03B 11.54

Mural Oncology Plc Aktie (MURA) Neueste Nachrichten

pulisher
Nov 20, 2024

Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer - The Manila Times

Nov 20, 2024
pulisher
Nov 20, 2024

Mural Oncology's Cancer Drug Shows 33% Response Rate in Melanoma Trial Data | MURA Stock News - StockTitan

Nov 20, 2024
pulisher
Nov 18, 2024

HC Wainwright Raises Earnings Estimates for Mural Oncology - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

HC Wainwright Predicts Stronger Earnings for Mural Oncology - MarketBeat

Nov 18, 2024
pulisher
Nov 16, 2024

MURAMural Oncology plc Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 16, 2024
pulisher
Nov 15, 2024

Armistice Capital, LLC Increases Stake in Mural Oncology PLC - GuruFocus.com

Nov 15, 2024
pulisher
Nov 13, 2024

Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Mural Oncology plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

Mural Oncology Reports 38% Lower Net Loss, Hits Trial Enrollment Milestones in Q3 | MURA Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 11, 2024

HC Wainwright Reaffirms "Buy" Rating for Mural Oncology (NASDAQ:MURA) - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Mural Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times

Nov 11, 2024
pulisher
Nov 11, 2024

Mural Oncology (MURA) to Present at Major Healthcare Investor Conferences | MURA Stock News - StockTitan

Nov 11, 2024
pulisher
Nov 07, 2024

Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Mural Oncology Reports Promising Cancer Trial Data, Plans Key 2025 Readouts | MURA Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Reduction in Mural Oncology PLC H - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 04, 2024
pulisher
Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock By Investing.com - Investing.com Canada

Nov 01, 2024
pulisher
Nov 01, 2024

Mural Oncology plc (NASDAQ:MURA) CFO Adam D. Cutler Sells 7,421 Shares - MarketBeat

Nov 01, 2024
pulisher
Nov 01, 2024

Mural Oncology CFO Adam Cutler sells $25,305 in company stock - Investing.com

Nov 01, 2024
pulisher
Oct 28, 2024

Short Interest in Mural Oncology plc (NASDAQ:MURA) Decreases By 15.7% - MarketBeat

Oct 28, 2024
pulisher
Oct 21, 2024

HC Wainwright Comments on Mural Oncology Q3 Earnings - MarketBeat

Oct 21, 2024
pulisher
Oct 17, 2024

Mural Oncology (NASDAQ:MURA) Coverage Initiated at HC Wainwright - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

H.C. Wainwright initiates coverage on Mural Oncology stock with Buy rating - Investing.com UK

Oct 17, 2024
pulisher
Oct 10, 2024

167,644 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Squarepoint Ops LLC - MarketBeat

Oct 10, 2024
pulisher
Oct 09, 2024

232,100 Shares in Mural Oncology plc (NASDAQ:MURA) Bought by Renaissance Technologies LLC - MarketBeat

Oct 09, 2024
pulisher
Oct 07, 2024

Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times

Oct 07, 2024
pulisher
Oct 04, 2024

Raymond James Begins Coverage on Mural Oncology (NASDAQ:MURA) - Defense World

Oct 04, 2024
pulisher
Oct 04, 2024

Mural Oncology (NASDAQ:MURA) Coverage Initiated by Analysts at Raymond James - MarketBeat

Oct 04, 2024
pulisher
Oct 02, 2024

Rhumbline Advisers Makes New $34,000 Investment in Mural Oncology plc (NASDAQ:MURA) - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

Point72 Asia Singapore Pte. Ltd. Invests $84,000 in Mural Oncology plc (NASDAQ:MURA) - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Mural Oncology Highlights Clinical Trials During It's Maiden Investor Day - Forbes

Sep 30, 2024
pulisher
Sep 28, 2024

Armistice Capital LLC Takes Position in Mural Oncology plc (NASDAQ:MURA) - Defense World

Sep 28, 2024
pulisher
Sep 27, 2024

1,688,000 Shares in Mural Oncology plc (NASDAQ:MURA) Acquired by Armistice Capital LLC - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Mural Oncology's First Virtual Investor Day to Highlight Late-Stage Clinical Progress - The Manila Times

Sep 26, 2024
pulisher
Sep 26, 2024

Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress - StockTitan

Sep 26, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new board member amid growth phase - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new director and audit chair - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new director and audit chair By Investing.com - Investing.com UK

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology Appoints Sachiyo Minegishi To Board - citybiz

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi - EIN News

Sep 23, 2024
pulisher
Sep 23, 2024

Mural Oncology appoints new board member amid growth phase By Investing.com - Investing.com South Africa

Sep 23, 2024
pulisher
Sep 20, 2024

Primecap Management Co. CA Purchases Shares of 235,551 Mural Oncology plc (NASDAQ:MURA) - MarketBeat

Sep 20, 2024
pulisher
Sep 19, 2024

Primecap Management Co. CA Buys New Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World

Sep 19, 2024
pulisher
Sep 17, 2024

Acadian Asset Management LLC Takes $998,000 Position in Mural Oncology plc (NASDAQ:MURA) - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Acadian Asset Management LLC Buys Shares of 318,536 Mural Oncology plc (NASDAQ:MURA) - Defense World

Sep 17, 2024
pulisher
Sep 10, 2024

Mural Oncology to Host First Virtual Investor Day on September 26, 2024 - ForexTV.com

Sep 10, 2024
pulisher
Sep 04, 2024

We Think Mural Oncology (NASDAQ:MURA) Needs To Drive Business Growth Carefully - Yahoo Finance

Sep 04, 2024
pulisher
Aug 27, 2024

Mural Oncology to Present at Two Upcoming Investor Conferences - ForexTV.com

Aug 27, 2024
pulisher
Aug 14, 2024

Mural Oncology plc (NASDAQ:MURA) Sees Significant Decrease in Short Interest - MarketBeat

Aug 14, 2024
pulisher
Aug 14, 2024

Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress - BioSpace

Aug 14, 2024

Finanzdaten der Mural Oncology Plc-Aktie (MURA)

Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Mural Oncology Plc-Aktie (MURA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Goodman Vicki L
Chief Medical Officer
Nov 07 '24
Sale
3.33
5,069
16,880
67,949
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Kapitalisierung:     |  Volumen (24h):